tissue plasminogen activators 组织型纤溶酶原激活物
plasminogen activators inhibitor 纤溶酶原激活物抑制物
tissue type plasminogen activators 组织型纤溶酶原激活剂
uterine tissue plasminogen activators 纤溶酶原激活物
recombinant tissue plasminogen activators 重组组织型纤溶酶原激活剂
Plasminogen activator inhibitor 1(PAI-1) is the main inhibitor of t-PA and other plasminogen activators (PA). The activity between PAI-1 and PAs is the most sufficient one in all PA inhibitors.
纤溶酶原激活物抑制物-1(plasminogen activator inhibitor-1,PAI-1)是目前所发现的纤溶酶原激活物(tissue plasmingen activator,t-PA;urokinase typeplasminogen activator,u-PA)抑制物中作用最强的蛋白质分子。
参考来源 - uCurrent fibrinolytic enzymes available for clinical use are mostly plasminogen activators. Despite their widespread use, all these agents have undesired side effectsand are very expensive.
目前临床使用的溶栓药物主要是纤溶酶原激活剂类,尽管这些药物的疗效肯定,但还存在许多缺陷,而且价格昂贵。
参考来源 - 纤溶酶高产菌株的分离筛选、发酵产酶及酶学性质的研究·2,447,543篇论文数据,部分数据来源于NoteExpress
应用推荐